Sinsin Pharmaceutical Co. Ltd Cash Flow Quality Index
Sinsin Pharmaceutical Co. Ltd cash flow quality index. Sinsin Pharmaceutical Co. Ltd (002800) has a Cash Flow Quality Index of 1.37x as of September 2025. Operating cash flow of ₩4.70 Billion exceeds net income of ₩3.42 Billion, indicating high earnings quality where cash backs reported profits. See 002800 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Sinsin Pharmaceutical Co. Ltd (2015–2024)
Cash flow quality index of Sinsin Pharmaceutical Co. Ltd from 2015 to 2024. Historical Cash Flow Quality Index for Sinsin Pharmaceutical Co. Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore 002800 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Sinsin Pharmaceutical Co. Ltd Cash Flow Quality Index by Year (2015–2024)
Sinsin Pharmaceutical Co. Ltd cash flow quality index by year from 2015 to 2024. Year-by-year earnings quality comparison for Sinsin Pharmaceutical Co. Ltd. For the full cash flow conversion analysis, see Sinsin Pharmaceutical Co. Ltd cash conversion from operations.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.24x | ₩5.94 Billion | ₩4.81 Billion | ▲ +46.0% |
| 2023 | 0.85x | ₩3.93 Billion | ₩4.65 Billion | ▼ -31.6% |
| 2022 | 1.24x | ₩5.46 Billion | ₩4.41 Billion | ▼ -75.9% |
| 2020 | 5.14x | ₩1.87 Billion | ₩362.66 Million | ▲ +344.0% |
| 2019 | -2.11x | ₩-4.51 Billion | ₩2.14 Billion | ▼ -888.4% |
| 2018 | 0.27x | ₩774.24 Million | ₩2.90 Billion | ▼ -78.9% |
| 2017 | 1.27x | ₩4.57 Billion | ₩3.60 Billion | ▲ +101.4% |
| 2016 | 0.63x | ₩2.79 Billion | ₩4.44 Billion | ▼ -53.3% |
| 2015 | 1.35x | ₩5.24 Billion | ₩3.89 Billion | — |